WALL, N.J., Oct. 01, 2021 (GLOBE NEWSWIRE) — BIO-key International, Inc. (NASDAQ: BKYI), an innovative provider of Identity and Access Management (IAM) and Identity-Bound Biometric solutions, today announced the company will be a sponsor and exhibitor at the 2021 Connect:ID Identity Conference and Exhibition, which will be held at the Walter E. Washington Convention Center in Washington, DC from October 5-6. BIO-key will be available for Q&A sessions and live demonstrations of their industry-leading Identity-Bound Biometric software and hardware solutions at booth 441. In addition, BIO-key�s own Michael DePasquale, Chairman and CEO, and Jim Sullivan, Senior Vice President of Strategy and Compliance and CLO, will be featured experts on multiple agenda sessions.
The Connect:ID conference will bring together industry leaders and pioneers to discuss current government policies and provide insights into the future of identity. The event is a world-class identity conference and exhibition, showcasing practical implementations of trusted identity solutions, and highlighting how disruptive technology and policy decisions are driving much-needed change. The theme of this years event is Identity: Reimagined.
Attendees are invited to stop by booth 441 to learn more about BIO-key’s unique line of IAM solutions, including biometric civil ID, Multi-Factor Authentication (MFA), and Single Sign On (SSO) for workforce, customer, and supplier identities, that feature their exclusive Identity-Bound Biometrics (IBB). IBB fills significant user experience gaps in mainstream MFA solutions by positively and conveniently identifying users, not just their device, in passwordless, phone-less, tokenless use cases, including for remote workforces and in situations, such as in retail, healthcare, manufacturing, and call centers, where users rove among shared workstations or might be distracted by phones or searching for a hardware token to sign in. BIO-key will be demonstrating IBB through several supported modes, including their new MobileAuthTM with PalmPositiveTM mobile application that uses a phone camera palm scan to positively authenticate users.
BIO-key will also have a full line of hardware devices on display including:
BIO-keys executive team members will be featured as speakers on the conference agenda as experts in the areas of identity and biometrics.
The conference is sponsored by one of the leading biometric advocacy organizations, the International Biometrics and Identification Industry Association (IBIA). Michael DePasquale, BIO-keys Chairman and CEO, is Vice Chairman and member of the Board of Directors of the organization and will participate in the keynote IBIA Plenary Session, on October 6, at 1:20 p.m. In this session, Challenges and Opportunities in Biometrics and Identity Management An IBIA Perspective, he will discuss how organizations can include biometric solutions in their identity management strategy.
Jim Sullivan, Senior Vice President of Strategy and Compliance, and Chief Legal Officer at BIO-key, will participate in multiple sessions including presenting on October 5, at 11:20 a.m. in the Seminar Theater on the topic, Youll know biometrics has arrived when to discuss the indicators that biometrics have become a mainstream authentication option, and at 2:00 p.m. to host a roundtable discussion on, Fiction, FUD, & Friction was the demonization of server biometrics a calculated attack? On October 6, Jim will then join a panel of experts at 11:05 a.m. to discuss Cutting Edge IAM.
“We welcome this opportunity to participate in Connect:ID, said Michael DePasquale. Were excited to attend and sponsor this event at such a critical time when we need to reimagine identity and come together to discuss and understand how we can use technology to confirm human identity in our physical and digital worlds.
For more information about the Connect:ID 2021 conference please visit the conference website. To learn more about BIO-keys IAM and Identity-Bound Biometric solutions please visit BIO-key’s website.
About BIO-key International, Inc. (www.BIO-key.com)
BIO-key has over two decades of expertise in providing authentication technology for thousands of organizations and millions of users and is revolutionizing authentication with biometric-centric, multifactor identity and access management (IAM) solutions, including its PortalGuard IAM solution, that provides convenient and secure access to devices, information, applications, and high-value transactions. BIO-key’s patented software and hardware solutions, with industry-leading biometric capabilities, enable large-scale on-premises and Identity-as-a-Service (IDaaS) solutions as well as customized enterprise and cloud solutions.
About CyberSecurity Breakthrough
Part of Tech Breakthrough, a leading market intelligence and recognition platform for global technology innovation and leadership, the CyberSecurity Breakthrough Awards program is devoted to honoring excellence in information security and cybersecurity technology companies, products and people. The CyberSecurity Breakthrough Awards provide a platform for public recognition around the achievements of breakthrough information security companies and products in categories including Cloud Security, Threat Detection, Risk Management, Fraud Prevention, Mobile Security, Web and Email Security, UTM, Firewall and more. For more information visit CyberSecurityBreakthrough.com.
BIO-key Safe Harbor Statement
All statements contained in this press release other than statements of historical facts are “forward-looking statements” as defined in the Private Securities Litigation Reform Act of 1995 (the “Act”). The words “estimate,” “project,” “intends,” “expects,” “anticipates,” “believes,” and similar expressions are intended to identify forward-looking statements. Such forward-looking statements are made based on management’s beliefs, as well as assumptions made by, and information currently available to, management pursuant to the “safe harbor” provisions of the Act. These statements are not guarantees of future performance or events and are subject to risks and uncertainties that may cause actual results to differ materially from those included within or implied by such forward-looking statements. These risks and uncertainties include, without limitation, our history of losses and limited revenue; our ability to raise additional capital; our ability to protect our intellectual property; changes in business conditions; changes in our sales strategy and product development plans; changes in the marketplace; continued services of our executive management team; security breaches; competition in the biometric technology industry; market acceptance of biometric products generally and our products under development; our ability to execute and deliver on contracts in Africa; our ability to expand into Asia, Africa and other foreign markets; the duration and severity of the current coronavirus COVID-19 pandemic and its effect on our business operations, sales cycles, personnel, and the geographic markets in which we operate; delays in the development of products and statements of assumption underlying any of the foregoing as well as other factors set forth under the caption see “Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2020 and other filings with the Securities and Exchange Commission. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date made. Except as required by law, the Company undertakes no obligation to disclose any revision to these forward-looking statements whether as a result of new information, future events, or otherwise. Additionally, there may be other factors of which the Company is not currently aware that may affect matters discussed in forward-looking statements and may also cause actual results to differ materially from those discussed. In particular, the consequences of the coronavirus outbreak to economic conditions and the industry in general and the financial position and operating results of our Company, in particular, have been material, are changing rapidly, and cannot be predicted.
Engage with BIO-key:
Facebook Corporate: https://www.facebook.com/BIOkeyInternational/
LinkedIn Corporate: https://www.linkedin.com/company/bio-key-international
Twitter Corporate: @BIOkeyIntl
Twitter Investors: @BIO_keyIR
StockTwits: BIO_keyIR
BIO-key Media Contact:
Erin Knapp
Matter Communications
BIO-key@matternow.com
914-260-3158
Investor Contacts:
William Jones, David Collins
Catalyst IR
BKYI@catalyst-ir.com
212-924-9800
CAIRO, EGYPT - Media OutReach Newswire - 23 December 2024 - Eand, Novo Nordisk, BSH,…
Trend Vision One™ – Email and Collaboration Security is a critical part of Trend’s centralized…
SINGAPORE - Media OutReach Newswire - 23 December 2024 - Madame Tussauds Singapore is proud…
BANGALORE, INDIA / SINGAPORE - Media OutReach Newswire - 23 December 2024 - GangaGen announced…
TAIPEI, TAIWAN - Media OutReach Newswire - 23 December 2024 – The 2024 Christmasland in…
Hungarian-based technology leader underscores its commitment to education, sustainability, and innovation SINGAPORE - Media OutReach…